Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Research Industries/Vascular Technologies

This article was originally published in The Gray Sheet

Executive Summary

Enter exclusive, worldwide marketing agreement under which Research Industries will distribute two Vascular Technologies probes that are "targeted for introduction in early fiscal 1994" (year beginning July 1). One probe "provides real-time pH and temperature in a patient's heart during bypass surgery," while the other, "by means of ultrasound, locates a patient's mammary artery to be salvaged for bypass graft material and also confirms that a new artery graft is open and functioning prior to concluding the surgery," Research Industries says.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000239

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel